Global NK1 Receptor Antagonist Market Research Report 2026(Status and Outlook)
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on NK1 Receptor Antagonist competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.NK1 receptor antagonists (Neurokinin-1 receptor antagonists) are a class of medications that prevent and control chemotherapy-induced nausea and vomiting (CINV) by blocking the binding of substance P to the NK1 receptors in the central nervous system. These agents are typically used in combination with 5-HT3 receptor antagonists and corticosteroids to effectively manage both acute and delayed phases of CINV, and they are considered standard supportive care in moderate to highly emetogenic chemotherapy regimens.
The global NK1 Receptor Antagonist market size was estimated at USD 708.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 5.70% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global NK1 Receptor Antagonist market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global NK1 Receptor Antagonist market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the NK1 Receptor Antagonist market.
Global NK1 Receptor Antagonist Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Merck
Helsinn Healthcare
TerSera Therapeutics
Heron Therapeutics
Glenmark
Torrent Pharmaceuticals
Fresenius Kabi
Chia Tai Tianqing Pharmaceutical
Qilu Pharmaceutical
Jiangsu Hengrui Pharmaceuticals
Beijing Sihuan Pharmaceutical
Yichang Humanwell Pharmaceutical
Hansoh Pharma
Luoxin Pharmaceutical
Market Segmentation (by Type)
Aprepitant
Rolapitant
Fosaprepitant
Netupitant
Maropitant
Other
Market Segmentation (by Application)
Hospital
Specialty Clinic
Geographic Segmentation
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the NK1 Receptor Antagonist Market
Overview of the regional outlook of the NK1 Receptor Antagonist Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the NK1 Receptor Antagonist Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of NK1 Receptor Antagonist, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global NK1 Receptor Antagonist market size was estimated at USD 708.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 5.70% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global NK1 Receptor Antagonist market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global NK1 Receptor Antagonist market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the NK1 Receptor Antagonist market.
Global NK1 Receptor Antagonist Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Merck
Helsinn Healthcare
TerSera Therapeutics
Heron Therapeutics
Glenmark
Torrent Pharmaceuticals
Fresenius Kabi
Chia Tai Tianqing Pharmaceutical
Qilu Pharmaceutical
Jiangsu Hengrui Pharmaceuticals
Beijing Sihuan Pharmaceutical
Yichang Humanwell Pharmaceutical
Hansoh Pharma
Luoxin Pharmaceutical
Market Segmentation (by Type)
Aprepitant
Rolapitant
Fosaprepitant
Netupitant
Maropitant
Other
Market Segmentation (by Application)
Hospital
Specialty Clinic
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the NK1 Receptor Antagonist Market
Overview of the regional outlook of the NK1 Receptor Antagonist Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the NK1 Receptor Antagonist Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of NK1 Receptor Antagonist, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of NK1 Receptor Antagonist
1.2 Key Market Segments
1.2.1 NK1 Receptor Antagonist Segment by Type
1.2.2 NK1 Receptor Antagonist Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NK1 RECEPTOR ANTAGONIST MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global NK1 Receptor Antagonist Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global NK1 Receptor Antagonist Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NK1 RECEPTOR ANTAGONIST MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global NK1 Receptor Antagonist Product Life Cycle
3.3 Global NK1 Receptor Antagonist Sales by Manufacturers (2020-2025)
3.4 Global NK1 Receptor Antagonist Revenue Market Share by Manufacturers (2020-2025)
3.5 NK1 Receptor Antagonist Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global NK1 Receptor Antagonist Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 NK1 Receptor Antagonist Market Competitive Situation and Trends
3.8.1 NK1 Receptor Antagonist Market Concentration Rate
3.8.2 Global 5 and 10 Largest NK1 Receptor Antagonist Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 NK1 RECEPTOR ANTAGONIST INDUSTRY CHAIN ANALYSIS
4.1 NK1 Receptor Antagonist Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NK1 RECEPTOR ANTAGONIST MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global NK1 Receptor Antagonist Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to NK1 Receptor Antagonist Market
5.7 ESG Ratings of Leading Companies
6 NK1 RECEPTOR ANTAGONIST MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global NK1 Receptor Antagonist Sales Market Share by Type (2020-2025)
6.3 Global NK1 Receptor Antagonist Market Size by Type (2020-2025)
6.4 Global NK1 Receptor Antagonist Price by Type (2020-2025)
7 NK1 RECEPTOR ANTAGONIST MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global NK1 Receptor Antagonist Market Sales by Application (2020-2025)
7.3 Global NK1 Receptor Antagonist Market Size (M USD) by Application (2020-2025)
7.4 Global NK1 Receptor Antagonist Sales Growth Rate by Application (2020-2025)
8 NK1 RECEPTOR ANTAGONIST MARKET SALES BY REGION
8.1 Global NK1 Receptor Antagonist Sales by Region
8.1.1 Global NK1 Receptor Antagonist Sales by Region
8.1.2 Global NK1 Receptor Antagonist Sales Market Share by Region
8.2 Global NK1 Receptor Antagonist Market Size by Region
8.2.1 Global NK1 Receptor Antagonist Market Size by Region
8.2.2 Global NK1 Receptor Antagonist Market Size by Region
8.3 North America
8.3.1 North America NK1 Receptor Antagonist Sales by Country
8.3.2 North America NK1 Receptor Antagonist Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe NK1 Receptor Antagonist Sales by Country
8.4.2 Europe NK1 Receptor Antagonist Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific NK1 Receptor Antagonist Sales by Region
8.5.2 Asia Pacific NK1 Receptor Antagonist Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America NK1 Receptor Antagonist Sales by Country
8.6.2 South America NK1 Receptor Antagonist Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa NK1 Receptor Antagonist Sales by Region
8.7.2 Middle East and Africa NK1 Receptor Antagonist Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 NK1 RECEPTOR ANTAGONIST MARKET PRODUCTION BY REGION
9.1 Global Production of NK1 Receptor Antagonist by Region(2020-2025)
9.2 Global NK1 Receptor Antagonist Revenue Market Share by Region (2020-2025)
9.3 Global NK1 Receptor Antagonist Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America NK1 Receptor Antagonist Production
9.4.1 North America NK1 Receptor Antagonist Production Growth Rate (2020-2025)
9.4.2 North America NK1 Receptor Antagonist Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe NK1 Receptor Antagonist Production
9.5.1 Europe NK1 Receptor Antagonist Production Growth Rate (2020-2025)
9.5.2 Europe NK1 Receptor Antagonist Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan NK1 Receptor Antagonist Production (2020-2025)
9.6.1 Japan NK1 Receptor Antagonist Production Growth Rate (2020-2025)
9.6.2 Japan NK1 Receptor Antagonist Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China NK1 Receptor Antagonist Production (2020-2025)
9.7.1 China NK1 Receptor Antagonist Production Growth Rate (2020-2025)
9.7.2 China NK1 Receptor Antagonist Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Merck
10.1.1 Merck Basic Information
10.1.2 Merck NK1 Receptor Antagonist Product Overview
10.1.3 Merck NK1 Receptor Antagonist Product Market Performance
10.1.4 Merck Business Overview
10.1.5 Merck SWOT Analysis
10.1.6 Merck Recent Developments
10.2 Helsinn Healthcare
10.2.1 Helsinn Healthcare Basic Information
10.2.2 Helsinn Healthcare NK1 Receptor Antagonist Product Overview
10.2.3 Helsinn Healthcare NK1 Receptor Antagonist Product Market Performance
10.2.4 Helsinn Healthcare Business Overview
10.2.5 Helsinn Healthcare SWOT Analysis
10.2.6 Helsinn Healthcare Recent Developments
10.3 TerSera Therapeutics
10.3.1 TerSera Therapeutics Basic Information
10.3.2 TerSera Therapeutics NK1 Receptor Antagonist Product Overview
10.3.3 TerSera Therapeutics NK1 Receptor Antagonist Product Market Performance
10.3.4 TerSera Therapeutics Business Overview
10.3.5 TerSera Therapeutics SWOT Analysis
10.3.6 TerSera Therapeutics Recent Developments
10.4 Heron Therapeutics
10.4.1 Heron Therapeutics Basic Information
10.4.2 Heron Therapeutics NK1 Receptor Antagonist Product Overview
10.4.3 Heron Therapeutics NK1 Receptor Antagonist Product Market Performance
10.4.4 Heron Therapeutics Business Overview
10.4.5 Heron Therapeutics Recent Developments
10.5 Glenmark
10.5.1 Glenmark Basic Information
10.5.2 Glenmark NK1 Receptor Antagonist Product Overview
10.5.3 Glenmark NK1 Receptor Antagonist Product Market Performance
10.5.4 Glenmark Business Overview
10.5.5 Glenmark Recent Developments
10.6 Torrent Pharmaceuticals
10.6.1 Torrent Pharmaceuticals Basic Information
10.6.2 Torrent Pharmaceuticals NK1 Receptor Antagonist Product Overview
10.6.3 Torrent Pharmaceuticals NK1 Receptor Antagonist Product Market Performance
10.6.4 Torrent Pharmaceuticals Business Overview
10.6.5 Torrent Pharmaceuticals Recent Developments
10.7 Fresenius Kabi
10.7.1 Fresenius Kabi Basic Information
10.7.2 Fresenius Kabi NK1 Receptor Antagonist Product Overview
10.7.3 Fresenius Kabi NK1 Receptor Antagonist Product Market Performance
10.7.4 Fresenius Kabi Business Overview
10.7.5 Fresenius Kabi Recent Developments
10.8 Chia Tai Tianqing Pharmaceutical
10.8.1 Chia Tai Tianqing Pharmaceutical Basic Information
10.8.2 Chia Tai Tianqing Pharmaceutical NK1 Receptor Antagonist Product Overview
10.8.3 Chia Tai Tianqing Pharmaceutical NK1 Receptor Antagonist Product Market Performance
10.8.4 Chia Tai Tianqing Pharmaceutical Business Overview
10.8.5 Chia Tai Tianqing Pharmaceutical Recent Developments
10.9 Qilu Pharmaceutical
10.9.1 Qilu Pharmaceutical Basic Information
10.9.2 Qilu Pharmaceutical NK1 Receptor Antagonist Product Overview
10.9.3 Qilu Pharmaceutical NK1 Receptor Antagonist Product Market Performance
10.9.4 Qilu Pharmaceutical Business Overview
10.9.5 Qilu Pharmaceutical Recent Developments
10.10 Jiangsu Hengrui Pharmaceuticals
10.10.1 Jiangsu Hengrui Pharmaceuticals Basic Information
10.10.2 Jiangsu Hengrui Pharmaceuticals NK1 Receptor Antagonist Product Overview
10.10.3 Jiangsu Hengrui Pharmaceuticals NK1 Receptor Antagonist Product Market Performance
10.10.4 Jiangsu Hengrui Pharmaceuticals Business Overview
10.10.5 Jiangsu Hengrui Pharmaceuticals Recent Developments
10.11 Beijing Sihuan Pharmaceutical
10.11.1 Beijing Sihuan Pharmaceutical Basic Information
10.11.2 Beijing Sihuan Pharmaceutical NK1 Receptor Antagonist Product Overview
10.11.3 Beijing Sihuan Pharmaceutical NK1 Receptor Antagonist Product Market Performance
10.11.4 Beijing Sihuan Pharmaceutical Business Overview
10.11.5 Beijing Sihuan Pharmaceutical Recent Developments
10.12 Yichang Humanwell Pharmaceutical
10.12.1 Yichang Humanwell Pharmaceutical Basic Information
10.12.2 Yichang Humanwell Pharmaceutical NK1 Receptor Antagonist Product Overview
10.12.3 Yichang Humanwell Pharmaceutical NK1 Receptor Antagonist Product Market Performance
10.12.4 Yichang Humanwell Pharmaceutical Business Overview
10.12.5 Yichang Humanwell Pharmaceutical Recent Developments
10.13 Hansoh Pharma
10.13.1 Hansoh Pharma Basic Information
10.13.2 Hansoh Pharma NK1 Receptor Antagonist Product Overview
10.13.3 Hansoh Pharma NK1 Receptor Antagonist Product Market Performance
10.13.4 Hansoh Pharma Business Overview
10.13.5 Hansoh Pharma Recent Developments
10.14 Luoxin Pharmaceutical
10.14.1 Luoxin Pharmaceutical Basic Information
10.14.2 Luoxin Pharmaceutical NK1 Receptor Antagonist Product Overview
10.14.3 Luoxin Pharmaceutical NK1 Receptor Antagonist Product Market Performance
10.14.4 Luoxin Pharmaceutical Business Overview
10.14.5 Luoxin Pharmaceutical Recent Developments
11 NK1 RECEPTOR ANTAGONIST MARKET FORECAST BY REGION
11.1 Global NK1 Receptor Antagonist Market Size Forecast
11.2 Global NK1 Receptor Antagonist Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe NK1 Receptor Antagonist Market Size Forecast by Country
11.2.3 Asia Pacific NK1 Receptor Antagonist Market Size Forecast by Region
11.2.4 South America NK1 Receptor Antagonist Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of NK1 Receptor Antagonist by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global NK1 Receptor Antagonist Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of NK1 Receptor Antagonist by Type (2026-2035)
12.1.2 Global NK1 Receptor Antagonist Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of NK1 Receptor Antagonist by Type (2026-2035)
12.2 Global NK1 Receptor Antagonist Market Forecast by Application (2026-2035)
12.2.1 Global NK1 Receptor Antagonist Sales (K MT) Forecast by Application
12.2.2 Global NK1 Receptor Antagonist Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of NK1 Receptor Antagonist
1.2 Key Market Segments
1.2.1 NK1 Receptor Antagonist Segment by Type
1.2.2 NK1 Receptor Antagonist Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NK1 RECEPTOR ANTAGONIST MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global NK1 Receptor Antagonist Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global NK1 Receptor Antagonist Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NK1 RECEPTOR ANTAGONIST MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global NK1 Receptor Antagonist Product Life Cycle
3.3 Global NK1 Receptor Antagonist Sales by Manufacturers (2020-2025)
3.4 Global NK1 Receptor Antagonist Revenue Market Share by Manufacturers (2020-2025)
3.5 NK1 Receptor Antagonist Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global NK1 Receptor Antagonist Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 NK1 Receptor Antagonist Market Competitive Situation and Trends
3.8.1 NK1 Receptor Antagonist Market Concentration Rate
3.8.2 Global 5 and 10 Largest NK1 Receptor Antagonist Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 NK1 RECEPTOR ANTAGONIST INDUSTRY CHAIN ANALYSIS
4.1 NK1 Receptor Antagonist Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NK1 RECEPTOR ANTAGONIST MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global NK1 Receptor Antagonist Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to NK1 Receptor Antagonist Market
5.7 ESG Ratings of Leading Companies
6 NK1 RECEPTOR ANTAGONIST MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global NK1 Receptor Antagonist Sales Market Share by Type (2020-2025)
6.3 Global NK1 Receptor Antagonist Market Size by Type (2020-2025)
6.4 Global NK1 Receptor Antagonist Price by Type (2020-2025)
7 NK1 RECEPTOR ANTAGONIST MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global NK1 Receptor Antagonist Market Sales by Application (2020-2025)
7.3 Global NK1 Receptor Antagonist Market Size (M USD) by Application (2020-2025)
7.4 Global NK1 Receptor Antagonist Sales Growth Rate by Application (2020-2025)
8 NK1 RECEPTOR ANTAGONIST MARKET SALES BY REGION
8.1 Global NK1 Receptor Antagonist Sales by Region
8.1.1 Global NK1 Receptor Antagonist Sales by Region
8.1.2 Global NK1 Receptor Antagonist Sales Market Share by Region
8.2 Global NK1 Receptor Antagonist Market Size by Region
8.2.1 Global NK1 Receptor Antagonist Market Size by Region
8.2.2 Global NK1 Receptor Antagonist Market Size by Region
8.3 North America
8.3.1 North America NK1 Receptor Antagonist Sales by Country
8.3.2 North America NK1 Receptor Antagonist Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe NK1 Receptor Antagonist Sales by Country
8.4.2 Europe NK1 Receptor Antagonist Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific NK1 Receptor Antagonist Sales by Region
8.5.2 Asia Pacific NK1 Receptor Antagonist Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America NK1 Receptor Antagonist Sales by Country
8.6.2 South America NK1 Receptor Antagonist Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa NK1 Receptor Antagonist Sales by Region
8.7.2 Middle East and Africa NK1 Receptor Antagonist Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 NK1 RECEPTOR ANTAGONIST MARKET PRODUCTION BY REGION
9.1 Global Production of NK1 Receptor Antagonist by Region(2020-2025)
9.2 Global NK1 Receptor Antagonist Revenue Market Share by Region (2020-2025)
9.3 Global NK1 Receptor Antagonist Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America NK1 Receptor Antagonist Production
9.4.1 North America NK1 Receptor Antagonist Production Growth Rate (2020-2025)
9.4.2 North America NK1 Receptor Antagonist Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe NK1 Receptor Antagonist Production
9.5.1 Europe NK1 Receptor Antagonist Production Growth Rate (2020-2025)
9.5.2 Europe NK1 Receptor Antagonist Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan NK1 Receptor Antagonist Production (2020-2025)
9.6.1 Japan NK1 Receptor Antagonist Production Growth Rate (2020-2025)
9.6.2 Japan NK1 Receptor Antagonist Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China NK1 Receptor Antagonist Production (2020-2025)
9.7.1 China NK1 Receptor Antagonist Production Growth Rate (2020-2025)
9.7.2 China NK1 Receptor Antagonist Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Merck
10.1.1 Merck Basic Information
10.1.2 Merck NK1 Receptor Antagonist Product Overview
10.1.3 Merck NK1 Receptor Antagonist Product Market Performance
10.1.4 Merck Business Overview
10.1.5 Merck SWOT Analysis
10.1.6 Merck Recent Developments
10.2 Helsinn Healthcare
10.2.1 Helsinn Healthcare Basic Information
10.2.2 Helsinn Healthcare NK1 Receptor Antagonist Product Overview
10.2.3 Helsinn Healthcare NK1 Receptor Antagonist Product Market Performance
10.2.4 Helsinn Healthcare Business Overview
10.2.5 Helsinn Healthcare SWOT Analysis
10.2.6 Helsinn Healthcare Recent Developments
10.3 TerSera Therapeutics
10.3.1 TerSera Therapeutics Basic Information
10.3.2 TerSera Therapeutics NK1 Receptor Antagonist Product Overview
10.3.3 TerSera Therapeutics NK1 Receptor Antagonist Product Market Performance
10.3.4 TerSera Therapeutics Business Overview
10.3.5 TerSera Therapeutics SWOT Analysis
10.3.6 TerSera Therapeutics Recent Developments
10.4 Heron Therapeutics
10.4.1 Heron Therapeutics Basic Information
10.4.2 Heron Therapeutics NK1 Receptor Antagonist Product Overview
10.4.3 Heron Therapeutics NK1 Receptor Antagonist Product Market Performance
10.4.4 Heron Therapeutics Business Overview
10.4.5 Heron Therapeutics Recent Developments
10.5 Glenmark
10.5.1 Glenmark Basic Information
10.5.2 Glenmark NK1 Receptor Antagonist Product Overview
10.5.3 Glenmark NK1 Receptor Antagonist Product Market Performance
10.5.4 Glenmark Business Overview
10.5.5 Glenmark Recent Developments
10.6 Torrent Pharmaceuticals
10.6.1 Torrent Pharmaceuticals Basic Information
10.6.2 Torrent Pharmaceuticals NK1 Receptor Antagonist Product Overview
10.6.3 Torrent Pharmaceuticals NK1 Receptor Antagonist Product Market Performance
10.6.4 Torrent Pharmaceuticals Business Overview
10.6.5 Torrent Pharmaceuticals Recent Developments
10.7 Fresenius Kabi
10.7.1 Fresenius Kabi Basic Information
10.7.2 Fresenius Kabi NK1 Receptor Antagonist Product Overview
10.7.3 Fresenius Kabi NK1 Receptor Antagonist Product Market Performance
10.7.4 Fresenius Kabi Business Overview
10.7.5 Fresenius Kabi Recent Developments
10.8 Chia Tai Tianqing Pharmaceutical
10.8.1 Chia Tai Tianqing Pharmaceutical Basic Information
10.8.2 Chia Tai Tianqing Pharmaceutical NK1 Receptor Antagonist Product Overview
10.8.3 Chia Tai Tianqing Pharmaceutical NK1 Receptor Antagonist Product Market Performance
10.8.4 Chia Tai Tianqing Pharmaceutical Business Overview
10.8.5 Chia Tai Tianqing Pharmaceutical Recent Developments
10.9 Qilu Pharmaceutical
10.9.1 Qilu Pharmaceutical Basic Information
10.9.2 Qilu Pharmaceutical NK1 Receptor Antagonist Product Overview
10.9.3 Qilu Pharmaceutical NK1 Receptor Antagonist Product Market Performance
10.9.4 Qilu Pharmaceutical Business Overview
10.9.5 Qilu Pharmaceutical Recent Developments
10.10 Jiangsu Hengrui Pharmaceuticals
10.10.1 Jiangsu Hengrui Pharmaceuticals Basic Information
10.10.2 Jiangsu Hengrui Pharmaceuticals NK1 Receptor Antagonist Product Overview
10.10.3 Jiangsu Hengrui Pharmaceuticals NK1 Receptor Antagonist Product Market Performance
10.10.4 Jiangsu Hengrui Pharmaceuticals Business Overview
10.10.5 Jiangsu Hengrui Pharmaceuticals Recent Developments
10.11 Beijing Sihuan Pharmaceutical
10.11.1 Beijing Sihuan Pharmaceutical Basic Information
10.11.2 Beijing Sihuan Pharmaceutical NK1 Receptor Antagonist Product Overview
10.11.3 Beijing Sihuan Pharmaceutical NK1 Receptor Antagonist Product Market Performance
10.11.4 Beijing Sihuan Pharmaceutical Business Overview
10.11.5 Beijing Sihuan Pharmaceutical Recent Developments
10.12 Yichang Humanwell Pharmaceutical
10.12.1 Yichang Humanwell Pharmaceutical Basic Information
10.12.2 Yichang Humanwell Pharmaceutical NK1 Receptor Antagonist Product Overview
10.12.3 Yichang Humanwell Pharmaceutical NK1 Receptor Antagonist Product Market Performance
10.12.4 Yichang Humanwell Pharmaceutical Business Overview
10.12.5 Yichang Humanwell Pharmaceutical Recent Developments
10.13 Hansoh Pharma
10.13.1 Hansoh Pharma Basic Information
10.13.2 Hansoh Pharma NK1 Receptor Antagonist Product Overview
10.13.3 Hansoh Pharma NK1 Receptor Antagonist Product Market Performance
10.13.4 Hansoh Pharma Business Overview
10.13.5 Hansoh Pharma Recent Developments
10.14 Luoxin Pharmaceutical
10.14.1 Luoxin Pharmaceutical Basic Information
10.14.2 Luoxin Pharmaceutical NK1 Receptor Antagonist Product Overview
10.14.3 Luoxin Pharmaceutical NK1 Receptor Antagonist Product Market Performance
10.14.4 Luoxin Pharmaceutical Business Overview
10.14.5 Luoxin Pharmaceutical Recent Developments
11 NK1 RECEPTOR ANTAGONIST MARKET FORECAST BY REGION
11.1 Global NK1 Receptor Antagonist Market Size Forecast
11.2 Global NK1 Receptor Antagonist Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe NK1 Receptor Antagonist Market Size Forecast by Country
11.2.3 Asia Pacific NK1 Receptor Antagonist Market Size Forecast by Region
11.2.4 South America NK1 Receptor Antagonist Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of NK1 Receptor Antagonist by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global NK1 Receptor Antagonist Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of NK1 Receptor Antagonist by Type (2026-2035)
12.1.2 Global NK1 Receptor Antagonist Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of NK1 Receptor Antagonist by Type (2026-2035)
12.2 Global NK1 Receptor Antagonist Market Forecast by Application (2026-2035)
12.2.1 Global NK1 Receptor Antagonist Sales (K MT) Forecast by Application
12.2.2 Global NK1 Receptor Antagonist Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global NK1 Receptor Antagonist Market Size by Type (M USD)
Table 4. Global NK1 Receptor Antagonist Market Size by Application
Table 5. NK1 Receptor Antagonist Market Size Comparison by Region (M USD)
Table 6. Global NK1 Receptor Antagonist Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global NK1 Receptor Antagonist Sales Market Share by Manufacturers (2020-2025)
Table 8. Global NK1 Receptor Antagonist Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global NK1 Receptor Antagonist Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NK1 Receptor Antagonist as of 2025)
Table 11. Global Market NK1 Receptor Antagonist Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global NK1 Receptor Antagonist Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. NK1 Receptor Antagonist Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global NK1 Receptor Antagonist Sales by Type (K MT)
Table 27. Global NK1 Receptor Antagonist Market Size by Type (M USD)
Table 28. Global NK1 Receptor Antagonist Sales (K MT) by Type (2020-2025)
Table 29. Global NK1 Receptor Antagonist Sales Market Share by Type (2020-2025)
Table 30. Global NK1 Receptor Antagonist Market Size (M USD) by Type (2020-2025)
Table 31. Global NK1 Receptor Antagonist Market Share by Type (2020-2025)
Table 32. Global NK1 Receptor Antagonist Price (USD/KG) by Type (2020-2025)
Table 33. Global NK1 Receptor Antagonist Sales (K MT) by Application
Table 34. Global NK1 Receptor Antagonist Market Size by Application
Table 35. Global NK1 Receptor Antagonist Sales by Application (2020-2025) & (K MT)
Table 36. Global NK1 Receptor Antagonist Sales Market Share by Application (2020-2025)
Table 37. Global NK1 Receptor Antagonist Market Size by Application (2020-2025) & (M USD)
Table 38. Global NK1 Receptor Antagonist Market Share by Application (2020-2025)
Table 39. Global NK1 Receptor Antagonist Sales Growth Rate by Application (2020-2025)
Table 40. Global NK1 Receptor Antagonist Sales by Region (2020-2025) & (K MT)
Table 41. Global NK1 Receptor Antagonist Sales Market Share by Region (2020-2025)
Table 42. Global NK1 Receptor Antagonist Market Size by Region (2020-2025) & (M USD)
Table 43. Global NK1 Receptor Antagonist Market Size by Region (2020-2025)
Table 44. North America NK1 Receptor Antagonist Sales by Country (2020-2025) & (K MT)
Table 45. North America NK1 Receptor Antagonist Market Size by Country (2020-2025) & (M USD)
Table 46. Europe NK1 Receptor Antagonist Sales by Country (2020-2025) & (K MT)
Table 47. Europe NK1 Receptor Antagonist Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific NK1 Receptor Antagonist Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific NK1 Receptor Antagonist Market Size by Region (2020-2025) & (M USD)
Table 50. South America NK1 Receptor Antagonist Sales by Country (2020-2025) & (K MT)
Table 51. South America NK1 Receptor Antagonist Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa NK1 Receptor Antagonist Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa NK1 Receptor Antagonist Market Size by Region (2020-2025) & (M USD)
Table 54. Global NK1 Receptor Antagonist Production (K MT) by Region(2020-2025)
Table 55. Global NK1 Receptor Antagonist Revenue (US$ Million) by Region (2020-2025)
Table 56. Global NK1 Receptor Antagonist Revenue Market Share by Region (2020-2025)
Table 57. Global NK1 Receptor Antagonist Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America NK1 Receptor Antagonist Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe NK1 Receptor Antagonist Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan NK1 Receptor Antagonist Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China NK1 Receptor Antagonist Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Merck Basic Information
Table 63. Merck NK1 Receptor Antagonist Product Overview
Table 64. Merck NK1 Receptor Antagonist Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Merck Business Overview
Table 66. Merck SWOT Analysis
Table 67. Merck Recent Developments
Table 68. Helsinn Healthcare Basic Information
Table 69. Helsinn Healthcare NK1 Receptor Antagonist Product Overview
Table 70. Helsinn Healthcare NK1 Receptor Antagonist Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Helsinn Healthcare Business Overview
Table 72. Helsinn Healthcare SWOT Analysis
Table 73. Helsinn Healthcare Recent Developments
Table 74. TerSera Therapeutics Basic Information
Table 75. TerSera Therapeutics NK1 Receptor Antagonist Product Overview
Table 76. TerSera Therapeutics NK1 Receptor Antagonist Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. TerSera Therapeutics Business Overview
Table 78. TerSera Therapeutics SWOT Analysis
Table 79. TerSera Therapeutics Recent Developments
Table 80. Heron Therapeutics Basic Information
Table 81. Heron Therapeutics NK1 Receptor Antagonist Product Overview
Table 82. Heron Therapeutics NK1 Receptor Antagonist Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Heron Therapeutics Business Overview
Table 84. Heron Therapeutics Recent Developments
Table 85. Glenmark Basic Information
Table 86. Glenmark NK1 Receptor Antagonist Product Overview
Table 87. Glenmark NK1 Receptor Antagonist Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Glenmark Business Overview
Table 89. Glenmark Recent Developments
Table 90. Torrent Pharmaceuticals Basic Information
Table 91. Torrent Pharmaceuticals NK1 Receptor Antagonist Product Overview
Table 92. Torrent Pharmaceuticals NK1 Receptor Antagonist Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Torrent Pharmaceuticals Business Overview
Table 94. Torrent Pharmaceuticals Recent Developments
Table 95. Fresenius Kabi Basic Information
Table 96. Fresenius Kabi NK1 Receptor Antagonist Product Overview
Table 97. Fresenius Kabi NK1 Receptor Antagonist Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Fresenius Kabi Business Overview
Table 99. Fresenius Kabi Recent Developments
Table 100. Chia Tai Tianqing Pharmaceutical Basic Information
Table 101. Chia Tai Tianqing Pharmaceutical NK1 Receptor Antagonist Product Overview
Table 102. Chia Tai Tianqing Pharmaceutical NK1 Receptor Antagonist Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Chia Tai Tianqing Pharmaceutical Business Overview
Table 104. Chia Tai Tianqing Pharmaceutical Recent Developments
Table 105. Qilu Pharmaceutical Basic Information
Table 106. Qilu Pharmaceutical NK1 Receptor Antagonist Product Overview
Table 107. Qilu Pharmaceutical NK1 Receptor Antagonist Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Qilu Pharmaceutical Business Overview
Table 109. Qilu Pharmaceutical Recent Developments
Table 110. Jiangsu Hengrui Pharmaceuticals Basic Information
Table 111. Jiangsu Hengrui Pharmaceuticals NK1 Receptor Antagonist Product Overview
Table 112. Jiangsu Hengrui Pharmaceuticals NK1 Receptor Antagonist Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Jiangsu Hengrui Pharmaceuticals Business Overview
Table 114. Jiangsu Hengrui Pharmaceuticals Recent Developments
Table 115. Beijing Sihuan Pharmaceutical Basic Information
Table 116. Beijing Sihuan Pharmaceutical NK1 Receptor Antagonist Product Overview
Table 117. Beijing Sihuan Pharmaceutical NK1 Receptor Antagonist Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Beijing Sihuan Pharmaceutical Business Overview
Table 119. Beijing Sihuan Pharmaceutical Recent Developments
Table 120. Yichang Humanwell Pharmaceutical Basic Information
Table 121. Yichang Humanwell Pharmaceutical NK1 Receptor Antagonist Product Overview
Table 122. Yichang Humanwell Pharmaceutical NK1 Receptor Antagonist Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Yichang Humanwell Pharmaceutical Business Overview
Table 124. Yichang Humanwell Pharmaceutical Recent Developments
Table 125. Hansoh Pharma Basic Information
Table 126. Hansoh Pharma NK1 Receptor Antagonist Product Overview
Table 127. Hansoh Pharma NK1 Receptor Antagonist Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Hansoh Pharma Business Overview
Table 129. Hansoh Pharma Recent Developments
Table 130. Luoxin Pharmaceutical Basic Information
Table 131. Luoxin Pharmaceutical NK1 Receptor Antagonist Product Overview
Table 132. Luoxin Pharmaceutical NK1 Receptor Antagonist Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Luoxin Pharmaceutical Business Overview
Table 134. Luoxin Pharmaceutical Recent Developments
Table 135. Global NK1 Receptor Antagonist Sales Forecast by Region (2026-2035) & (K MT)
Table 136. Global NK1 Receptor Antagonist Market Size Forecast by Region (2026-2035) & (M USD)
Table 137. North America NK1 Receptor Antagonist Sales Forecast by Country (2026-2035) & (K MT)
Table 138. North America NK1 Receptor Antagonist Market Size Forecast by Country (2026-2035) & (M USD)
Table 139. Europe NK1 Receptor Antagonist Sales Forecast by Country (2026-2035) & (K MT)
Table 140. Europe NK1 Receptor Antagonist Market Size Forecast by Country (2026-2035) & (M USD)
Table 141. Asia Pacific NK1 Receptor Antagonist Sales Forecast by Region (2026-2035) & (K MT)
Table 142. Asia Pacific NK1 Receptor Antagonist Market Size Forecast by Region (2026-2035) & (M USD)
Table 143. South America NK1 Receptor Antagonist Sales Forecast by Country (2026-2035) & (K MT)
Table 144. South America NK1 Receptor Antagonist Market Size Forecast by Country (2026-2035) & (M USD)
Table 145. Middle East and Africa NK1 Receptor Antagonist Sales Forecast by Country (2026-2035) & (Units)
Table 146. Middle East and Africa NK1 Receptor Antagonist Market Size Forecast by Country (2026-2035) & (M USD)
Table 147. Global NK1 Receptor Antagonist Sales Forecast by Type (2026-2035) & (K MT)
Table 148. Global NK1 Receptor Antagonist Market Size Forecast by Type (2026-2035) & (M USD)
Table 149. Global NK1 Receptor Antagonist Price Forecast by Type (2026-2035) & (USD/KG)
Table 150. Global NK1 Receptor Antagonist Sales (K MT) Forecast by Application (2026-2035)
Table 151. Global NK1 Receptor Antagonist Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global NK1 Receptor Antagonist Market Size by Type (M USD)
Table 4. Global NK1 Receptor Antagonist Market Size by Application
Table 5. NK1 Receptor Antagonist Market Size Comparison by Region (M USD)
Table 6. Global NK1 Receptor Antagonist Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global NK1 Receptor Antagonist Sales Market Share by Manufacturers (2020-2025)
Table 8. Global NK1 Receptor Antagonist Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global NK1 Receptor Antagonist Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NK1 Receptor Antagonist as of 2025)
Table 11. Global Market NK1 Receptor Antagonist Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global NK1 Receptor Antagonist Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. NK1 Receptor Antagonist Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global NK1 Receptor Antagonist Sales by Type (K MT)
Table 27. Global NK1 Receptor Antagonist Market Size by Type (M USD)
Table 28. Global NK1 Receptor Antagonist Sales (K MT) by Type (2020-2025)
Table 29. Global NK1 Receptor Antagonist Sales Market Share by Type (2020-2025)
Table 30. Global NK1 Receptor Antagonist Market Size (M USD) by Type (2020-2025)
Table 31. Global NK1 Receptor Antagonist Market Share by Type (2020-2025)
Table 32. Global NK1 Receptor Antagonist Price (USD/KG) by Type (2020-2025)
Table 33. Global NK1 Receptor Antagonist Sales (K MT) by Application
Table 34. Global NK1 Receptor Antagonist Market Size by Application
Table 35. Global NK1 Receptor Antagonist Sales by Application (2020-2025) & (K MT)
Table 36. Global NK1 Receptor Antagonist Sales Market Share by Application (2020-2025)
Table 37. Global NK1 Receptor Antagonist Market Size by Application (2020-2025) & (M USD)
Table 38. Global NK1 Receptor Antagonist Market Share by Application (2020-2025)
Table 39. Global NK1 Receptor Antagonist Sales Growth Rate by Application (2020-2025)
Table 40. Global NK1 Receptor Antagonist Sales by Region (2020-2025) & (K MT)
Table 41. Global NK1 Receptor Antagonist Sales Market Share by Region (2020-2025)
Table 42. Global NK1 Receptor Antagonist Market Size by Region (2020-2025) & (M USD)
Table 43. Global NK1 Receptor Antagonist Market Size by Region (2020-2025)
Table 44. North America NK1 Receptor Antagonist Sales by Country (2020-2025) & (K MT)
Table 45. North America NK1 Receptor Antagonist Market Size by Country (2020-2025) & (M USD)
Table 46. Europe NK1 Receptor Antagonist Sales by Country (2020-2025) & (K MT)
Table 47. Europe NK1 Receptor Antagonist Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific NK1 Receptor Antagonist Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific NK1 Receptor Antagonist Market Size by Region (2020-2025) & (M USD)
Table 50. South America NK1 Receptor Antagonist Sales by Country (2020-2025) & (K MT)
Table 51. South America NK1 Receptor Antagonist Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa NK1 Receptor Antagonist Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa NK1 Receptor Antagonist Market Size by Region (2020-2025) & (M USD)
Table 54. Global NK1 Receptor Antagonist Production (K MT) by Region(2020-2025)
Table 55. Global NK1 Receptor Antagonist Revenue (US$ Million) by Region (2020-2025)
Table 56. Global NK1 Receptor Antagonist Revenue Market Share by Region (2020-2025)
Table 57. Global NK1 Receptor Antagonist Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America NK1 Receptor Antagonist Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe NK1 Receptor Antagonist Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan NK1 Receptor Antagonist Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China NK1 Receptor Antagonist Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Merck Basic Information
Table 63. Merck NK1 Receptor Antagonist Product Overview
Table 64. Merck NK1 Receptor Antagonist Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Merck Business Overview
Table 66. Merck SWOT Analysis
Table 67. Merck Recent Developments
Table 68. Helsinn Healthcare Basic Information
Table 69. Helsinn Healthcare NK1 Receptor Antagonist Product Overview
Table 70. Helsinn Healthcare NK1 Receptor Antagonist Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Helsinn Healthcare Business Overview
Table 72. Helsinn Healthcare SWOT Analysis
Table 73. Helsinn Healthcare Recent Developments
Table 74. TerSera Therapeutics Basic Information
Table 75. TerSera Therapeutics NK1 Receptor Antagonist Product Overview
Table 76. TerSera Therapeutics NK1 Receptor Antagonist Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. TerSera Therapeutics Business Overview
Table 78. TerSera Therapeutics SWOT Analysis
Table 79. TerSera Therapeutics Recent Developments
Table 80. Heron Therapeutics Basic Information
Table 81. Heron Therapeutics NK1 Receptor Antagonist Product Overview
Table 82. Heron Therapeutics NK1 Receptor Antagonist Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Heron Therapeutics Business Overview
Table 84. Heron Therapeutics Recent Developments
Table 85. Glenmark Basic Information
Table 86. Glenmark NK1 Receptor Antagonist Product Overview
Table 87. Glenmark NK1 Receptor Antagonist Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Glenmark Business Overview
Table 89. Glenmark Recent Developments
Table 90. Torrent Pharmaceuticals Basic Information
Table 91. Torrent Pharmaceuticals NK1 Receptor Antagonist Product Overview
Table 92. Torrent Pharmaceuticals NK1 Receptor Antagonist Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Torrent Pharmaceuticals Business Overview
Table 94. Torrent Pharmaceuticals Recent Developments
Table 95. Fresenius Kabi Basic Information
Table 96. Fresenius Kabi NK1 Receptor Antagonist Product Overview
Table 97. Fresenius Kabi NK1 Receptor Antagonist Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Fresenius Kabi Business Overview
Table 99. Fresenius Kabi Recent Developments
Table 100. Chia Tai Tianqing Pharmaceutical Basic Information
Table 101. Chia Tai Tianqing Pharmaceutical NK1 Receptor Antagonist Product Overview
Table 102. Chia Tai Tianqing Pharmaceutical NK1 Receptor Antagonist Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Chia Tai Tianqing Pharmaceutical Business Overview
Table 104. Chia Tai Tianqing Pharmaceutical Recent Developments
Table 105. Qilu Pharmaceutical Basic Information
Table 106. Qilu Pharmaceutical NK1 Receptor Antagonist Product Overview
Table 107. Qilu Pharmaceutical NK1 Receptor Antagonist Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Qilu Pharmaceutical Business Overview
Table 109. Qilu Pharmaceutical Recent Developments
Table 110. Jiangsu Hengrui Pharmaceuticals Basic Information
Table 111. Jiangsu Hengrui Pharmaceuticals NK1 Receptor Antagonist Product Overview
Table 112. Jiangsu Hengrui Pharmaceuticals NK1 Receptor Antagonist Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Jiangsu Hengrui Pharmaceuticals Business Overview
Table 114. Jiangsu Hengrui Pharmaceuticals Recent Developments
Table 115. Beijing Sihuan Pharmaceutical Basic Information
Table 116. Beijing Sihuan Pharmaceutical NK1 Receptor Antagonist Product Overview
Table 117. Beijing Sihuan Pharmaceutical NK1 Receptor Antagonist Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Beijing Sihuan Pharmaceutical Business Overview
Table 119. Beijing Sihuan Pharmaceutical Recent Developments
Table 120. Yichang Humanwell Pharmaceutical Basic Information
Table 121. Yichang Humanwell Pharmaceutical NK1 Receptor Antagonist Product Overview
Table 122. Yichang Humanwell Pharmaceutical NK1 Receptor Antagonist Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Yichang Humanwell Pharmaceutical Business Overview
Table 124. Yichang Humanwell Pharmaceutical Recent Developments
Table 125. Hansoh Pharma Basic Information
Table 126. Hansoh Pharma NK1 Receptor Antagonist Product Overview
Table 127. Hansoh Pharma NK1 Receptor Antagonist Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Hansoh Pharma Business Overview
Table 129. Hansoh Pharma Recent Developments
Table 130. Luoxin Pharmaceutical Basic Information
Table 131. Luoxin Pharmaceutical NK1 Receptor Antagonist Product Overview
Table 132. Luoxin Pharmaceutical NK1 Receptor Antagonist Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Luoxin Pharmaceutical Business Overview
Table 134. Luoxin Pharmaceutical Recent Developments
Table 135. Global NK1 Receptor Antagonist Sales Forecast by Region (2026-2035) & (K MT)
Table 136. Global NK1 Receptor Antagonist Market Size Forecast by Region (2026-2035) & (M USD)
Table 137. North America NK1 Receptor Antagonist Sales Forecast by Country (2026-2035) & (K MT)
Table 138. North America NK1 Receptor Antagonist Market Size Forecast by Country (2026-2035) & (M USD)
Table 139. Europe NK1 Receptor Antagonist Sales Forecast by Country (2026-2035) & (K MT)
Table 140. Europe NK1 Receptor Antagonist Market Size Forecast by Country (2026-2035) & (M USD)
Table 141. Asia Pacific NK1 Receptor Antagonist Sales Forecast by Region (2026-2035) & (K MT)
Table 142. Asia Pacific NK1 Receptor Antagonist Market Size Forecast by Region (2026-2035) & (M USD)
Table 143. South America NK1 Receptor Antagonist Sales Forecast by Country (2026-2035) & (K MT)
Table 144. South America NK1 Receptor Antagonist Market Size Forecast by Country (2026-2035) & (M USD)
Table 145. Middle East and Africa NK1 Receptor Antagonist Sales Forecast by Country (2026-2035) & (Units)
Table 146. Middle East and Africa NK1 Receptor Antagonist Market Size Forecast by Country (2026-2035) & (M USD)
Table 147. Global NK1 Receptor Antagonist Sales Forecast by Type (2026-2035) & (K MT)
Table 148. Global NK1 Receptor Antagonist Market Size Forecast by Type (2026-2035) & (M USD)
Table 149. Global NK1 Receptor Antagonist Price Forecast by Type (2026-2035) & (USD/KG)
Table 150. Global NK1 Receptor Antagonist Sales (K MT) Forecast by Application (2026-2035)
Table 151. Global NK1 Receptor Antagonist Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of NK1 Receptor Antagonist
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global NK1 Receptor Antagonist Market Size (M USD), 2025-2035
Figure 5. Global NK1 Receptor Antagonist Market Size (M USD) (2020-2035)
Figure 6. Global NK1 Receptor Antagonist Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. NK1 Receptor Antagonist Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global NK1 Receptor Antagonist Product Life Cycle
Figure 13. NK1 Receptor Antagonist Sales Share by Manufacturers in 2025
Figure 14. Global NK1 Receptor Antagonist Revenue Share by Manufacturers in 2025
Figure 15. NK1 Receptor Antagonist Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market NK1 Receptor Antagonist Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by NK1 Receptor Antagonist Revenue in 2025
Figure 18. Industry Chain Map of NK1 Receptor Antagonist
Figure 19. Global NK1 Receptor Antagonist Market PEST Analysis
Figure 20. Global NK1 Receptor Antagonist Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global NK1 Receptor Antagonist Market Share by Type
Figure 27. Sales Market Share of NK1 Receptor Antagonist by Type (2020-2025)
Figure 28. Sales Market Share of NK1 Receptor Antagonist by Type in 2025
Figure 29. Market Share of NK1 Receptor Antagonist by Type (2020-2025)
Figure 30. Market Share of NK1 Receptor Antagonist by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global NK1 Receptor Antagonist Market Share by Application
Figure 33. Global NK1 Receptor Antagonist Sales Market Share by Application (2020-2025)
Figure 34. Global NK1 Receptor Antagonist Sales Market Share by Application in 2025
Figure 35. Global NK1 Receptor Antagonist Market Share by Application (2020-2025)
Figure 36. Global NK1 Receptor Antagonist Market Share by Application in 2025
Figure 37. Global NK1 Receptor Antagonist Sales Growth Rate by Application (2020-2025)
Figure 38. Global NK1 Receptor Antagonist Sales Market Share by Region (2020-2025)
Figure 39. Global NK1 Receptor Antagonist Market Size by Region (2020-2025)
Figure 40. North America NK1 Receptor Antagonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America NK1 Receptor Antagonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America NK1 Receptor Antagonist Sales Market Share by Country in 2024
Figure 43. North America NK1 Receptor Antagonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America NK1 Receptor Antagonist Market Size by Country in 2024
Figure 45. U.S. NK1 Receptor Antagonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. NK1 Receptor Antagonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada NK1 Receptor Antagonist Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada NK1 Receptor Antagonist Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico NK1 Receptor Antagonist Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico NK1 Receptor Antagonist Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe NK1 Receptor Antagonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe NK1 Receptor Antagonist Sales Market Share by Country in 2024
Figure 53. Europe NK1 Receptor Antagonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe NK1 Receptor Antagonist Market Size by Country in 2024
Figure 55. Germany NK1 Receptor Antagonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany NK1 Receptor Antagonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France NK1 Receptor Antagonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France NK1 Receptor Antagonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. NK1 Receptor Antagonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. NK1 Receptor Antagonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy NK1 Receptor Antagonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy NK1 Receptor Antagonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain NK1 Receptor Antagonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain NK1 Receptor Antagonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific NK1 Receptor Antagonist Sales and Growth Rate (K MT)
Figure 66. Asia Pacific NK1 Receptor Antagonist Sales Market Share by Region in 2024
Figure 67. Asia Pacific NK1 Receptor Antagonist Market Size by Region in 2024
Figure 68. China NK1 Receptor Antagonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China NK1 Receptor Antagonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan NK1 Receptor Antagonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan NK1 Receptor Antagonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea NK1 Receptor Antagonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea NK1 Receptor Antagonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India NK1 Receptor Antagonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India NK1 Receptor Antagonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia NK1 Receptor Antagonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia NK1 Receptor Antagonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America NK1 Receptor Antagonist Sales and Growth Rate (K MT)
Figure 79. South America NK1 Receptor Antagonist Sales Market Share by Country in 2024
Figure 80. South America NK1 Receptor Antagonist Market Size and Growth Rate (M USD)
Figure 81. South America NK1 Receptor Antagonist Market Size by Country in 2024
Figure 82. Brazil NK1 Receptor Antagonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil NK1 Receptor Antagonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina NK1 Receptor Antagonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina NK1 Receptor Antagonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia NK1 Receptor Antagonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia NK1 Receptor Antagonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa NK1 Receptor Antagonist Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa NK1 Receptor Antagonist Sales Market Share by Region in 2024
Figure 90. Middle East and Africa NK1 Receptor Antagonist Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa NK1 Receptor Antagonist Market Size by Region in 2024
Figure 92. Saudi Arabia NK1 Receptor Antagonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia NK1 Receptor Antagonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE NK1 Receptor Antagonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE NK1 Receptor Antagonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt NK1 Receptor Antagonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt NK1 Receptor Antagonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria NK1 Receptor Antagonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria NK1 Receptor Antagonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa NK1 Receptor Antagonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa NK1 Receptor Antagonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global NK1 Receptor Antagonist Production Market Share by Region (2020-2025)
Figure 103. North America NK1 Receptor Antagonist Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe NK1 Receptor Antagonist Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan NK1 Receptor Antagonist Production (K MT) Growth Rate (2020-2025)
Figure 106. China NK1 Receptor Antagonist Production (K MT) Growth Rate (2020-2025)
Figure 107. Global NK1 Receptor Antagonist Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global NK1 Receptor Antagonist Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global NK1 Receptor Antagonist Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global NK1 Receptor Antagonist Market Share Forecast by Type (2026-2035)
Figure 111. Global NK1 Receptor Antagonist Sales Forecast by Application (2026-2035)
Figure 112. Global NK1 Receptor Antagonist Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of NK1 Receptor Antagonist
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global NK1 Receptor Antagonist Market Size (M USD), 2025-2035
Figure 5. Global NK1 Receptor Antagonist Market Size (M USD) (2020-2035)
Figure 6. Global NK1 Receptor Antagonist Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. NK1 Receptor Antagonist Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global NK1 Receptor Antagonist Product Life Cycle
Figure 13. NK1 Receptor Antagonist Sales Share by Manufacturers in 2025
Figure 14. Global NK1 Receptor Antagonist Revenue Share by Manufacturers in 2025
Figure 15. NK1 Receptor Antagonist Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market NK1 Receptor Antagonist Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by NK1 Receptor Antagonist Revenue in 2025
Figure 18. Industry Chain Map of NK1 Receptor Antagonist
Figure 19. Global NK1 Receptor Antagonist Market PEST Analysis
Figure 20. Global NK1 Receptor Antagonist Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global NK1 Receptor Antagonist Market Share by Type
Figure 27. Sales Market Share of NK1 Receptor Antagonist by Type (2020-2025)
Figure 28. Sales Market Share of NK1 Receptor Antagonist by Type in 2025
Figure 29. Market Share of NK1 Receptor Antagonist by Type (2020-2025)
Figure 30. Market Share of NK1 Receptor Antagonist by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global NK1 Receptor Antagonist Market Share by Application
Figure 33. Global NK1 Receptor Antagonist Sales Market Share by Application (2020-2025)
Figure 34. Global NK1 Receptor Antagonist Sales Market Share by Application in 2025
Figure 35. Global NK1 Receptor Antagonist Market Share by Application (2020-2025)
Figure 36. Global NK1 Receptor Antagonist Market Share by Application in 2025
Figure 37. Global NK1 Receptor Antagonist Sales Growth Rate by Application (2020-2025)
Figure 38. Global NK1 Receptor Antagonist Sales Market Share by Region (2020-2025)
Figure 39. Global NK1 Receptor Antagonist Market Size by Region (2020-2025)
Figure 40. North America NK1 Receptor Antagonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America NK1 Receptor Antagonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America NK1 Receptor Antagonist Sales Market Share by Country in 2024
Figure 43. North America NK1 Receptor Antagonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America NK1 Receptor Antagonist Market Size by Country in 2024
Figure 45. U.S. NK1 Receptor Antagonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. NK1 Receptor Antagonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada NK1 Receptor Antagonist Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada NK1 Receptor Antagonist Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico NK1 Receptor Antagonist Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico NK1 Receptor Antagonist Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe NK1 Receptor Antagonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe NK1 Receptor Antagonist Sales Market Share by Country in 2024
Figure 53. Europe NK1 Receptor Antagonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe NK1 Receptor Antagonist Market Size by Country in 2024
Figure 55. Germany NK1 Receptor Antagonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany NK1 Receptor Antagonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France NK1 Receptor Antagonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France NK1 Receptor Antagonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. NK1 Receptor Antagonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. NK1 Receptor Antagonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy NK1 Receptor Antagonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy NK1 Receptor Antagonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain NK1 Receptor Antagonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain NK1 Receptor Antagonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific NK1 Receptor Antagonist Sales and Growth Rate (K MT)
Figure 66. Asia Pacific NK1 Receptor Antagonist Sales Market Share by Region in 2024
Figure 67. Asia Pacific NK1 Receptor Antagonist Market Size by Region in 2024
Figure 68. China NK1 Receptor Antagonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China NK1 Receptor Antagonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan NK1 Receptor Antagonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan NK1 Receptor Antagonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea NK1 Receptor Antagonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea NK1 Receptor Antagonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India NK1 Receptor Antagonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India NK1 Receptor Antagonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia NK1 Receptor Antagonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia NK1 Receptor Antagonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America NK1 Receptor Antagonist Sales and Growth Rate (K MT)
Figure 79. South America NK1 Receptor Antagonist Sales Market Share by Country in 2024
Figure 80. South America NK1 Receptor Antagonist Market Size and Growth Rate (M USD)
Figure 81. South America NK1 Receptor Antagonist Market Size by Country in 2024
Figure 82. Brazil NK1 Receptor Antagonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil NK1 Receptor Antagonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina NK1 Receptor Antagonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina NK1 Receptor Antagonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia NK1 Receptor Antagonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia NK1 Receptor Antagonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa NK1 Receptor Antagonist Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa NK1 Receptor Antagonist Sales Market Share by Region in 2024
Figure 90. Middle East and Africa NK1 Receptor Antagonist Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa NK1 Receptor Antagonist Market Size by Region in 2024
Figure 92. Saudi Arabia NK1 Receptor Antagonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia NK1 Receptor Antagonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE NK1 Receptor Antagonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE NK1 Receptor Antagonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt NK1 Receptor Antagonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt NK1 Receptor Antagonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria NK1 Receptor Antagonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria NK1 Receptor Antagonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa NK1 Receptor Antagonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa NK1 Receptor Antagonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global NK1 Receptor Antagonist Production Market Share by Region (2020-2025)
Figure 103. North America NK1 Receptor Antagonist Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe NK1 Receptor Antagonist Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan NK1 Receptor Antagonist Production (K MT) Growth Rate (2020-2025)
Figure 106. China NK1 Receptor Antagonist Production (K MT) Growth Rate (2020-2025)
Figure 107. Global NK1 Receptor Antagonist Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global NK1 Receptor Antagonist Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global NK1 Receptor Antagonist Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global NK1 Receptor Antagonist Market Share Forecast by Type (2026-2035)
Figure 111. Global NK1 Receptor Antagonist Sales Forecast by Application (2026-2035)
Figure 112. Global NK1 Receptor Antagonist Market Share Forecast by Application (2026-2035)
